We are live on
!
Find out more
Lord, Abbett & Co Portfolio holdings
AUM
$30.6B
1-Year Est. Return
57.44%
This Fund
S&P 500
This Quarter
Est. Return
+7.95%
1 Year Est. Return
+57.44%
3 Year Est. Return
+215.76%
5 Year Est. Return
+368.6%
10 Year Est. Return
+2,376.62%
AUM
$32.8B
AUM Growth
+$860M
(+2.7%)
Cap. Flow
-$1.63B
Cap. Flow
% of AUM
-4.97%
Top 10 Holdings %
Top 10 Hldgs %
10.27%
Holding
993
New
119
Increased
264
Reduced
386
Closed
137
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$125M |
| 2 |
Intel
INTC
|
+$119M |
| 3 |
Johnson Controls International
JCI
|
+$93.1M |
| 4 |
ALR
Alere Inc
ALR
|
+$92.3M |
| 5 |
TSRO
TESARO, Inc.
TSRO
|
+$78.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chubb
CB
|
+$135M |
| 2 |
TransDigm Group
TDG
|
+$95.6M |
| 3 |
AT&T
T
|
+$80.8M |
| 4 |
Johnson & Johnson
JNJ
|
+$80.5M |
| 5 |
EXAM
EXAMWORKS GROUP INC COM STK (DE)
EXAM
|
+$78.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.16% |
| 2 | Financials | 13.68% |
| 3 | Healthcare | 13.23% |
| 4 | Industrials | 13.17% |
| 5 | Consumer Discretionary | 8.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
MaxLinear
MXL
$5.88B
| $29M | 0.09% |
1,432,329
-961,726
| -40% | -$18.9M |
|
352
International Flavors & Fragrances
IFF
$19.5B
| $28.9M | 0.09% |
202,257
-67,959
| -25% | -$9.2M |
|
353
Unum
UNM
$13.8B
| $28.9M | 0.09% |
818,300
-97,900
| -11% | -$3.31M |
|
354
Charles River Laboratories
CRL
$10.8B
| $28.8M | 0.09% |
345,921
-16,250
| -4% | -$1.36M |
|
355
AbbVie
ABBV
$454B
| $28.8M | 0.09% |
456,506
-173,000
| -27% | -$11.2M |
|
356
Pentair
PNR
$10.2B
| $28.8M | 0.09% |
666,923
+258,639
| +63% | +$10.9M |
|
357
Rio Tinto
RIO
$150B
| $28.8M | 0.09% |
861,175
+65,790
| +8% | +$2.1M |
|
|
ENH
358
DELISTED
Endurance Specialty Holdings Ltd
ENH
| $28.5M | 0.09% |
436,178
-226,340
| -34% | -$15M |
|
|
AFSI
359
DELISTED
AmTrust Financial Services, Inc.
AFSI
| $28.4M | 0.09% |
1,058,500
-19,400
| -2% | -$498K |
|
360
Boston Scientific
BSX
$67.6B
| $28.3M | 0.09% |
1,190,686
-53,827
| -4% | -$1.28M |
|
361
Universal Electronics
UEIC
$57.6M
| $28.3M | 0.09% |
379,739
+250,328
| +193% | +$18.8M |
|
362
Cogent Communications
CCOI
$612M
| $27.9M | 0.09% |
757,562
-256,978
| -25% | -$9.92M |
|
363
Patrick Industries
PATK
$2.81B
| $27.9M | 0.09% |
1,013,319
-364,595
| -26% | -$10.3M |
|
364
Brinker International
EAT
$8.38B
| $27.2M | 0.08% |
540,100
+99,400
| +23% | +$5M |
|
365
Agios Pharmaceuticals
AGIO
$2.2B
| $26.9M | 0.08% |
508,469
+96,549
| +23% | +$4.2M |
|
366
Alaska Air
ALK
$5.3B
| $26.7M | 0.08% |
+405,343
| New | +$26.7M |
|
|
LNCE
367
DELISTED
Snyders-Lance, Inc.
LNCE
| $26.4M | 0.08% |
784,789
+41,565
| +6% | +$1.44M |
|
368
TJX Companies
TJX
$173B
| $26.2M | 0.08% |
700,946
-451,122
| -39% | -$17.7M |
|
369
Delta Air Lines
DAL
$57B
| $26.2M | 0.08% |
665,391
+548,991
| +472% | +$20.8M |
|
370
Bio-Techne
TECH
$11.2B
| $26.1M | 0.08% |
953,592
-293,872
| -24% | -$8.07M |
|
371
Quest Diagnostics
DGX
$25.6B
| $26.1M | 0.08% |
308,300
-7,100
| -2% | -$596K |
|
372
Nutanix
NTNX
$15.4B
| $26.1M | 0.08% |
+705,000
| New | +$26.1M |
|
|
HOUS
373
DELISTED
Anywhere Real Estate
HOUS
| $26M | 0.08% |
1,005,820
-9,336
| -0.9% | -$259K |
|
|
COR
374
DELISTED
Coresite Realty Corporation
COR
| $26M | 0.08% |
350,790
-493,893
| -58% | -$40.1M |
|
375
IMAX
IMAX
$2.47B
| $25.8M | 0.08% |
892,001
-101,538
| -10% | -$3.09M |
|
Similar funds
Lord, Abbett & Co's Q3 2016 Portfolio in Review
As of Q3 2016, Lord, Abbett & Co held 993 positions worth $32.8B, up 2.7% from $31.9B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Lord, Abbett & Co withdrew a net $1.63B in Q3 2016, closing 137 positions and reducing 386 holdings. Its most notable exit was EXAMWORKS GROUP INC COM STK (DE), an estimated $78.1M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Lord, Abbett & Co opened a new position in Abbott worth $124M.
- Lord, Abbett & Co's largest Q3 2016 buy was Abbott: 2,921,922 shares worth $124M.
- Lord, Abbett & Co added most to Intel in Q3 2016, an estimated $119M increase.
- Lord, Abbett & Co's biggest Q3 2016 reduction was Chubb, cutting an estimated $135M.
- Lord, Abbett & Co fully exited EXAMWORKS GROUP INC COM STK (DE) in Q3 2016, selling an estimated $78.1M.
- Lord, Abbett & Co's ten largest holdings make up 10% of its $32.8B portfolio in Q3 2016.
- Lord, Abbett & Co opened 119 new positions and closed 137 in Q3 2016.
- Lord, Abbett & Co's portfolio value rose 2.7% quarter-over-quarter to $32.8B.
Based on Lord, Abbett & Co's 13F filing for Q3 2016, filed 10 Nov 2016.